ALKS 9072 (ALKS 9070)

· Alkermes, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ALKS 9072 (ALKS 9070), covering 2016-10-27 to 2017-08-25. Get the full timeline:

Most recent: Clinical Trial Update: An Extension of a Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070) [Phase 3]